Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT05809921

Completed

Dual IntraVenous Thrombolysis Approach (DIVA) in Patients With Medium-vessel-occlusion Strokes: a Retrospective Study (DIVArétro)

Acute Ischemic Stroke Due to Medium-vessel-occlusion
NCT04782128

Active, not recruiting

Evaluation of RC28-E Injection in Diabetic Retinopathy

Diabetic Retinopathy
NCT03779191

Completed

Alectinib in Combination With Bevacizumab in ALK Positive NSCLC

ALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of Lung
NCT03032484

Completed

TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma

Astrocytoma
NCT05712642

Completed

A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity

Retinopathy of Prematurity
NCT01229072

Suspended

Safe Use of Heparin Sodium in Patients With Chronic Renal Failure. (Heparin)

Chronic Renal Failure
NCT05360979

Enrolling by invitation

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

Non-small Cell Lung Cancer
NCT02930941

Terminated

Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department

Epistaxis
NCT04954014

Terminated

Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients (BEVACOR)

Coronavirus Infection | ARDS, Human
NCT04986813

Completed

Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery

Trauma | Tranexamic Acid | Lower Extremity Fracture
NCT04912128

Completed

Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC (AnloSBRT)

Stereotactic Body Radiation Therapy
NCT03668054

Completed

Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)

Age-Related Macular Degeneration
NCT04518163

Unknown

Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa

Placenta Previa
NCT02287558

Completed

Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study

Hereditary Hemorrhagic Telangiectasia | Idiopathic Vascular Ectasia
NCT01937559

Completed

Topical Tranexamic Acid (TXA) in Joint Arthroplasty

Osteoarthritis | Hip Arthropathy | Shoulder Arthropathy
NCT03820206

Completed

The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women

Intraoperative Bleeding
NCT00419250

Completed

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | Leukemia, B-Cell, Chronic
NCT03715309

Unknown

R2 in the Treatment of Follicular Lymphoma

Follicular Lymphoma
NCT01342172

Terminated

Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma

Urinary Bladder Neoplasms
NCT01958918

Completed

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD (SALT)

Neovascular Age-related Macular Degeneration
NCT02511405

Completed

A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE) (GLOBE)

Glioblastoma
NCT00288015

Completed

Bevacizumab in Treating Patients With Angiosarcoma

Sarcoma
NCT02401945

Completed

A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration (VAPOR1)

Age-Related Macular Degeneration
NCT00923130

Completed

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Renal Cell Carcinoma
NCT01571284

Completed

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Colorectal Cancer Metastatic
NCT03131700

Withdrawn

Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator

Healthy
NCT03306836

Unknown

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2 (EAPCAAMHO2)

Arteriovenous Malformations | Cerebral Aneurysm
NCT01543568

Completed

Study for Recalcitrant Age Related Macular Degeneration (TURF)

Age Related Macular Degeneration
NCT02829346

Completed

Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty

Osteoarthritis, Knee
NCT01250379

Completed

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)

Breast Cancer
NCT01771081

Completed

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy (POLARIS)

Macular Degeneration | Macular Edema | Ophthalmology
NCT00545870

Completed

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Diabetic Retinopathy | Diabetic Macular Edema | Proliferative Diabetic Retinopathy
NCT01291121

Completed

Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion

Neovascular Age-related Macular Degeneration
NCT01217203

Completed

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse (KIRIMID)

Patients With Multiple Myeloma Experiencing a | First or Second Relapse
NCT02054078

Unknown

Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion

Malignant Pleural Effusion
NCT00434239

Unknown

Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia

Myelodysplasia
NCT00541307

Completed

GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER) (VIPER)

Peripheral Vascular Diseases
NCT01746563

Completed

Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy

Cardiovascular Diseases | Vascular Diseases | Eye Diseases | Diabetic Angiopathies | Retinal Diseases | Diabetic Retinopathy
NCT00802906

Completed

Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)

Central Serous Chorioretinopathy
NCT01190150

Completed

Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding (PREA)

Menorrhagia
NCT01437618

Completed

First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
NCT01350323

Completed

Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization

Age-related Macular Degeneration
NCT00985920

Completed

Topical Tranexamic Acid for Total Knee Arthroplasty

Total Knee Arthroplasty | Surgical Blood Loss
NCT01310478

Unknown

Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer

Colorectal Neoplasm
NCT00165477

Completed

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Glioblastoma | Gliosarcoma | Malignant Gliomas
NCT00239980

Completed

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Ovarian Cancer
NCT00531024

Completed

Systemic Avastin Therapy in Age-Related Macular Degeneration (BEAT-AMD)

Macular Degeneration
NCT00253396

Completed

Patients Preference With Self-Injection: The PRISM Study

Bruises
NCT00001763

Completed

Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection

Acquired Immunodeficiency Syndrome | Mycobacterium Avium-Intracellulare Infection
NCT00344617

Unknown

Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy

Polypoidal Choroidal Vasculopathy | Choroidal Neovascularisation

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations